1Bone, RA, Landrum, JT, Hime, GW, Cains, A & Zamor, J (1993) Stereochemistry of the human macular carotenoids. Invest Ophthalmol Vis Sci 34, 2033–2040.
2Landrum, JT & Bone, RA (2001) Lutein, zeaxanthin and the macular pigment. Arch Biochem Biophys 385, 28–40.
3Handelman, GJ, Dratz, EA, Reay, CC & Van Kuijk, JGM (1988) Carotenoids in the human macula and whole retina. Invest Ophthalmol Vis Sci 29, 850–855.
4Bone, RA, Landrum, JT, Friedes, CM, Gomez, MD & Kilburn, E (1997) Distribution of lutein and zeaxanthin stereoisomers in the human retina. Exp Eye Res 64, 211–218.
5Schalch, E (1992) Carotenoids in the retina – a review of their possible role in preventing or limiting damage caused by light and oxygen. In Free Radicals and Aging, pp. 280–298 [Emerit, I and Chance, B, editors]. Basel Switzerland: Birkhauser Verlag.
6O'Connell, E, Neelam, K, Nolan, JM, Au Eong, KG & Beatty, S (2006) Macular carotenoids and age-related maculopathy. Ann Acad Med Singapore 35, 821–830.
7Malinow, MR, Feeney-Burns, L, Person, LH, Klein, M & Neuringer, M (1980) Diet-related macular anomalies in monkeys. Invest Ophthalmol Vis Sci 19, 857–863.
8Dorey, CK, Toyoda, Y, Thompson, L, Garnett, KM, Sapunzatkis, M, Craft, NE, Nichols, C & Cheng, K (1997) Light-induced photoreceptor apoptosis is correlated with dietary and retinal levels of 3R,3′R-zeaxanthin. Invest Ophthalmol Vis Sci 38, S355.
9Maoka, T, Arai, A, Sinuzu, M & Matsuno, T (1986) The first isolation of entiomeric and meso-zeaxanthin in nature. Comp Biochem Physiol B 83, 121–124.
10Khachik, F, de Moura, FF, Zhao, DY, Aebischer, CP & Bernstein, PS (2002) Transformations of selected carotenoids in plasma, liver, and ocular tissues of humans and in nonprimate animal models. Invest Ophthalmol Vis Sci 43, 3383–3392.
11Johnson, EJ, Neuringer, M, Russell, RM, Schalch, W & Snodderly, DM (2005) Nutritional manipulation of primate retinas, III: effects of lutein or zeaxanthin supplementation on adipose tissue and retina of xanthophyll-free monkeys. Invest Ophthalmol Vis Sci 46, 692–702.
12Bhosale, P, Larson, AJ, Frederick, JM, Southwick, K, Thulin, CD & Bernstein, PS (2004) Identification and characterization of a Pi isoform of glutathione S-transferase (GSTP1) as a zeaxanthin-binding protein in the macula of the human eye. J Biol Chem 279, 49447–49454.
13Johansson, AS & Mannervik, B (2001) Human glutathione transferase A3-3, a highly efficient catalyst of double-bond isomerization in the biosynthetic pathway of steroid hormones. J Biol Chem 276, 33061–33065.
14Friedman, DS, O'Colmain, BJ, Munoz, B, et al. (2004) Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 122, 564–572.
15Evans, J & Wormald, R (1996) Is the incidence of registrable age-related macular degeneration increasing? Br J Ophthalmol 80, 9–14.
16Maruo, T, Ikebukuro, N, Kawanabe, K & Kubota, N (1991) Changes in causes of visual handicaps in Tokyo. Jpn J Ophthalmol 35, 268–272.
17Nebeling, LC, Forman, MR, Graubard, BI & Snyder, RA (1997) Changes to carotenoid intake in the United States: the 1987 and 1992 National Health interview surveys. J Am Diet Assoc 97, 991–996.
18Mares-Perlman, JA, Fisher, AI, Klein, R, Palta, M, Block, G, Millen, AE & Wright, JD (2001) Lutein and zeaxanthin in the diet and serum and their relation to age-related maculopathy in the Third National Health and Nutrition Examination Survey. Am J Epidemiol 153, 424–432.
19Thurnham, DI, Smith, E & Flora, PS (1988) Concurrent liquid-chromatographic assay of retinol, α-tocopherol, β-carotene, α-carotene, lycopene and β-cryptoxanthin in plasma with tocopherol acetate as internal standard. Clin Chem 34, 377–381.
20Bone, RA, Landrum, JT, Cao, Y, Howard, AN & Thurnham, DI (2006) Macular pigment response to a xanthophyll supplement of lutein, zeaxanthin and meso-zeaxanthin. Proc Nutr Soc 65, 105A.
21Montoya-Olvera, R, Elizondo-Mireles, J-R, Torres-Gomez, C-J & Torres-Quiroga, J-O (2003) .
22Rüttimann, A, Schiedt, K & Vecchi, M (1983) Separation of (3R, 3′R)-, (3R, 3′S; meso)-, (3S, 3′S)-Zeaxanthin, (3R, 3′R, 6′R)-, (3R, 3′S, 6′S)- and (3S, 3′S, 6′S)-Lutein via the dicarbamates of (S)-(+)-α-(1-naphthyl) ethyl isocyanate. J High Resolut Chromatogr 6, 612–616.
23Thurmann, PA, Schalch, W, Aebischer, C-P, Tenter, U & Cohn, W (2005) Plasma kinetics of lutein, zeaxanthin, and 3′-dehydro-lutein after multiple doses of a lutein supplement. Am J Clin Nutr 82, 88–97.
24Hartmann, D, Thurmann, PA, Spitzer, V, Schalch, W, Manner, B & Cohn, W (2004) Plasma kinetics of zeaxanthin and 3′-dehydro-lutein after multiple oral doses of synthetic zeaxanthin. Am J Clin Nutr 79, 410–417.
25Bone, RA, Landrum, JT, Cao, Y, Howard, AN & Alvarez-Calderon, F (2007) Macular pigment response to a supplement containing meso-zeaxanthin, lutein and zeaxanthin. Nutr Metabol 4, 12.
26Schiedt, K, Leuenberger, FJ, Vecchi, M & Glintz, E (1985) Absorption, retention and metabolic transformatiion of carotenoids in rainbow trout, salmon and chicken. Pure Appl Chem 57, 685–692.
27Goodman, DS, Blomstrand, R, Werner, B, Huang, HS & Shiratory, T (1966) The intestinal absorption and metabolism of vitamin A and β-carotene in man. J Clin Invest 45, 1615–1623.
28Thurnham, DI (2007) Bioequivalence of β-carotene and retinol. J Sci Food Agriculture 87, 13–39.
29Thurnham, DI, Mburu, ASW, Mwaniki, DL & de Wagt, A (2005) Micronutrients in childhood and the influence of subclinical inflammation. Proc Nutr Soc 64, 502–509.
30Erlinger, TP, Guallar, E, Miller, ER, Stolzenberg-Solomon, R & Appel, LJ (2001) Relationship between systemic markers of inflammation and serum β-carotene levels. Arch Intern Med 161, 1903–1908.
31Van Den Berg, H & Van Vliet, T (1998) Effect of simultaneous, single oral doses of β-carotene and retinyl ester responses in the triacylglycerol-rich lipoprotein fraction of men. Am J Clin Nutr 68, 82–89.
32Rock, CL, Swenseid, ME, Jacob, RA & McKee, RW (1992) Plasma carotenoid levels in human subjects fed a low carotenoid diet. J Nutr 122, 96–100.